Financial Post EN

Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH

ISS Cites Compelling Strategic Rationale, Favorable Market Reaction, and Strong Institutional Confidence in Recommending Shareholders Vote FOR the Transaction Resolution TORONTO — Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that Institutional Shareholder Services Inc. (“ISS”), a leading independent proxy advisory firm, […]

Mar 23, 2026 &03102323202631; 10:10 UTC financialpost.com Trending 3/5

Read original on financialpost.com ↗

→

Neutral impact

Sentiment score: +15/100

Moderate impact Short-term (days)

WHAT THIS MEANS

ISS, a major proxy advisory firm, recommends Organigram shareholders vote FOR the acquisition of Sanity Group GmbH, citing strategic rationale and favorable market reaction. This endorsement from an influential institutional advisor could facilitate deal approval, though cannabis sector volatility and regulatory uncertainties remain structural headwinds.

AI CONFIDENCE

60% High

SENTIMENT GAUGE

NEWS POWER SCORE

AFFECTED ASSETS

↑

OGI

OGIStock

Expected to rise

ISS recommendation reduces deal execution risk and may encourage institutional voting support; however, cannabis sector fundamentals and regulatory environment remain challenging

⇅

NASDAQ

NASDAQIndex

High volatility expected

Cannabis stocks are highly volatile; ISS support is positive but insufficient to overcome sector-wide headwinds

PRICE HISTORY

Loading chart...

⚡ SUGGESTED ACTION

ISS recommendation is a positive catalyst for deal closure, but avoid overweighting this signal. Cannabis sector fundamentals remain weak; use any near-term rally as a selling opportunity rather than a buy signal. Monitor shareholder vote outcome and regulatory developments.

KEY SIGNALS

Proxy advisory firm endorsement reduces deal uncertaintyInstitutional confidence signal may improve shareholder approval oddsCannabis sector remains structurally challenged by regulatory and profitability concernsMarket reaction already likely priced into stock before announcement

SECTORS INVOLVED

Cannabis/MarijuanaConsumer DiscretionaryHealthcare

Analysis generated on Mar 23, 2026 at 10:17 UTC

Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Financial Post. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Organigram Announces Independent Proxy Advisory Firm ISS Recommends Organigram Shareholders Vote FOR the Acquisition of Sanity Group GmbH

RELATED INTELLIGENCE